FFTY:NYE-Innovator IBD® 50 ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 27.47

Change

-0.17 (-0.62)%

Market Cap

N/A

Volume

0.05M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

-2.34 (-1.94%)

USD 15.82B
VOT Vanguard Mid-Cap Growth Index ..

-3.08 (-1.24%)

USD 14.48B
IJK iShares S&P Mid-Cap 400 Growth..

-1.31 (-1.54%)

USD 8.67B
XMMO Invesco S&P MidCap Momentum ET..

-1.43 (-1.24%)

USD 3.54B
IVOG Vanguard S&P Mid-Cap 400 Growt..

-1.32 (-1.25%)

USD 1.01B
ETHO Amplify ETF Trust

-0.45 (-0.80%)

USD 0.18B
CWS AdvisorShares Focused Equity E..

-0.25 (-0.38%)

USD 0.17B
BFOR Barron's 400 ETF

-0.59 (-0.85%)

USD 0.14B
IPO Renaissance IPO ETF

-0.95 (-2.38%)

USD 0.13B
PEXL Pacer US Export Leaders ETF

-0.42 (-0.88%)

USD 0.05B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.92% 69% C- 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.92% 69% C- 32% F
Trailing 12 Months  
Capital Gain 1.97% 56% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.97% 56% F 36% F
Trailing 5 Years  
Capital Gain 8.36% 11% F 26% F
Dividend Return 3.38% 17% F 6% D-
Total Return 11.74% 11% F 16% F
Average Annual (5 Year Horizon)  
Capital Gain -1.57% 11% F 25% F
Dividend Return -0.88% 11% F 17% F
Total Return 0.69% 61% D- 17% F
Risk Return Profile  
Volatility (Standard Deviation) 29.82% 22% F 35% F
Risk Adjusted Return -2.96% 11% F 19% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.